Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer
DOI10.1111/J.1541-0420.2011.01572.XzbMATH Open1274.62922OpenAlexW2049655669WikidataQ30502590 ScholiaQ30502590MaRDI QIDQ2893403FDOQ2893403
Authors: Yufan Zhao, Donglin Zeng, Mark A. Socinski, Michael R. Kosorok 
Publication date: 20 June 2012
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3138840
Recommendations
- Q-learning with censored data
- \(Q\)- and \(A\)-learning methods for estimating optimal dynamic treatment regimes
- Penalized Q-learning for dynamic treatment regimens
- New statistical learning methods for estimating optimal dynamic treatment regimes
- Tree-based reinforcement learning for estimating optimal dynamic treatment regimes
\(Q\)-learningpersonalized medicinereinforcement learningsupport vector regressionadaptive designdynamic treatment regimeindividualized therapymultistage decision problemsnonsmall cell lung cancer
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
Cites Work
Cited In (31)
- Flexible inference of optimal individualized treatment strategy in covariate adjusted randomization with multiple covariates
- Robust inference of conditional average treatment effects using dimension reduction
- Reinforcement learning-based control of drug dosing for cancer chemotherapy treatment
- Estimating individualized treatment rules using outcome weighted learning
- Functional feature construction for individualized treatment regimes
- Estimating optimal individualized treatment rules with multistate processes
- High-Dimensional Precision Medicine From Patient-Derived Xenografts
- Stochastic tree search for estimating optimal dynamic treatment regimes
- Using decision lists to construct interpretable and parsimonious treatment regimes
- On estimating optimal regime for treatment initiation time based on restricted mean residual lifetime
- Q-learning with censored data
- Recursively imputed survival trees
- Incorporating patient preferences into estimation of optimal individualized treatment rules
- Interpretable dynamic treatment regimes
- Learning Non-monotone Optimal Individualized Treatment Regimes
- Multicategory Angle-Based Learning for Estimating Optimal Dynamic Treatment Regimes With Censored Data
- \(i\)Fusion: individualized fusion learning
- Doubly-robust dynamic treatment regimen estimation via weighted least squares
- A survey of preference-based reinforcement learning methods
- A cure-rate model for Q-learning: estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients
- Estimating mean survival time: when is it possible?
- Estimating treatment effect heterogeneity in randomized program evaluation
- Deep reinforcement learning for personalized treatment recommendation
- Q-learning for estimating optimal dynamic treatment rules from observational data
- Deep spatial Q-learning for infectious disease control
- Sequential advantage selection for optimal treatment regime
- On sparse representation for optimal individualized treatment selection with penalized outcome weighted learning
- Optimal adaptive control of drug dosing using integral reinforcement learning
- Robust Q-learning
- Personalized dynamic treatment regimes in continuous time: a Bayesian approach for optimizing clinical decisions with timing
- Optimal Treatment Regimes: A Review and Empirical Comparison
This page was built for publication: Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2893403)
